» Articles » PMID: 3040199

Calcium Phosphate Phase Transformations in Serum

Overview
Specialty Pathology
Date 1987 Jul 1
PMID 3040199
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

A better knowledge of the pathological calcification mechanisms should provide a rational basis for their control. In the present study, dicalcium phosphate dihydrate (DCPD, CaHPO4 X 2H2O) was used as a source of calcium and phosphate ions to investigate the mechanism of formation of more basic and more insoluble calcium phosphates in ultrafiltered serum (u.f.s.). DCPD crystals were suspended in u.f.s. at 37 degrees C by constant stirring; samples were removed periodically for calcium and phosphate analysis and pH measurement. Occasionally, samples of solids were removed for X-ray diffraction. The experiments were carried out both with and without a 5.5% CO2 atmosphere. After initially becoming saturated with DCPD, the u.f.s. composition changed and became saturated with respect to octacalcium phosphate (OCP, Ca8H2(PO4)6 X 5H2O). At this point OCP crystals were detected in the solid phase by X-ray diffraction. Further stirring changed the composition so that it became undersaturated with both DCPD and OCP and shifted toward, but did not reach, a value so low as to be saturated with hydroxyapatite (OHAp, (Ca5(PO4)3OH). The presence of CO2 in the atmosphere slowed down, but did not prevent, the above sequence of events. The above results strongly suggest that calcifications, beneficial and pathological, that take place in serum may involve OCP as a precursor, which hydrolyzes in situ to a more basic apatitic product. The results also indicate that direct formation of OHAp in u.f.s. is a very slow process and may occur only rarely. The process appears to be similar in whole serum.

Citing Articles

Enhanced osteogenic capacity of octacalcium phosphate involving adsorption of stromal-derived factor-1 in a standardized defect of a rat femur.

Kanabuchi R, Hamai R, Mori Y, Hamada S, Shiwaku Y, Sai Y J Mater Sci Mater Med. 2025; 36(1):23.

PMID: 40019693 PMC: 11870905. DOI: 10.1007/s10856-025-06872-9.


Effect of Octacalcium Phosphate Crystals on the Osteogenic Differentiation of Tendon Stem/Progenitor Cells In Vitro.

Liu X, Shiwaku Y, Hamai R, Tsuchiya K, Takahashi T, Suzuki O Int J Mol Sci. 2023; 24(2).

PMID: 36674753 PMC: 9866338. DOI: 10.3390/ijms24021235.


Physical/Chemical Properties and Resorption Behavior of a Newly Developed Ca/P/S-Based Bone Substitute Material.

Yang B, Lee J, Ju C, Chern Lin J Materials (Basel). 2020; 13(16).

PMID: 32764505 PMC: 7475886. DOI: 10.3390/ma13163458.


A review of the bioactivity of hydraulic calcium silicate cements.

Niu L, Jiao K, Wang T, Zhang W, Camilleri J, Bergeron B J Dent. 2014; 42(5):517-33.

PMID: 24440449 PMC: 3995854. DOI: 10.1016/j.jdent.2013.12.015.


A comparison of epithelial cells, fibroblasts, and osteoblasts in dental implant titanium topographies.

Teng F, Ko C, Kuo H, Hu J, Lin J, Lou C Bioinorg Chem Appl. 2012; 2012:687291.

PMID: 22287942 PMC: 3263600. DOI: 10.1155/2012/687291.


References
1.
TUNG M, Brown W . An intermediate state in hydrolysis of amorphous calcium phosphate. Calcif Tissue Int. 1983; 35(6):783-90. DOI: 10.1007/BF02405124. View

2.
Meyer J, Eanes E . A thermodynamic analysis of the secondary transition in the spontaneous precipitation of calcium phosphate. Calcif Tissue Res. 1978; 25(3):209-16. DOI: 10.1007/BF02010771. View

3.
Eidelman N, Chow L, Brown W . Calcium phosphate saturation levels in ultrafiltered serum. Calcif Tissue Int. 1987; 40(2):71-8. DOI: 10.1007/BF02555708. View

4.
Larsen M, Thorsen A . A comparison of some effects of fluoride on apatite formation in vitro and in vivo. Calcif Tissue Int. 1984; 36(6):690-6. DOI: 10.1007/BF02405391. View

5.
Eanes E, Hailer A, Costa J . Calcium phosphate formation in aqueous suspensions of multilamellar liposomes. Calcif Tissue Int. 1984; 36(4):421-30. DOI: 10.1007/BF02405354. View